Language

Mycophenolate Mofetil CAS：128794-94-5

NAME:Mycophenolate mofetil | CAS No. 128794-94-5 | Dehydrogenase Inhibitor MF：C23H31NO7 MW：433.49 Appearance:white to beige powder COA:Provide Purity:97%+

Categories：

Life Science Chemicals

Pharmaceutical Intermediates

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

PRODUCT NAME	MycophenolateMofetil
CAS NO	128794-94-5
MP	95-96°C
BP	637.6±55.0 °C(Predicted)
DENSITY	1.222±0.06 g/cm3(Predicted)
STORAGE	2-8°C
DELIVERY	2-3DAYS
PACKAGE	According client's request

Description of Mycophenolate mofetil | CAS No. 128794-94-5

Synonym(s):

2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate

Mycophenolate mofetil (MMF) is a prodrug of mycophenolic acid (MPA), an inhibitor of inosine-5’-monophosphate dehydrogenase . It is used with other medicines (e.g., cyclosporine, steroid medicine) to lower the body’s natural immunity in patients who receive organ transplants (e.g., kidney, heart, or liver)

Applications of Mycophenolate mofetil | CAS No. 128794-94-5

1.Treatment of Immune Thrombocytopenic Purpura (ITP)
MMF has been used in the treatment of Immune Thrombocytopenic Purpura (ITP), a disorder characterized by a reduced blood platelet count, which increases the risk of hemorrhage .

2.Antibacterial and Antifungal Agent
Mycophenolate mofetil, part of the mycophenolic acid drug class, was first isolated from a Penicillium byproduct over 120 years ago and utilized as an antibacterial and antifungal agent

3.Anticancer Drug
During the 1960s, mycophenolic acid found application as an anticancer drug . There is continued interest in its use as an antineoplastic drug

4.Treatment of Autoimmune Diseases
MMF may have use in autoimmune diseases, including rheumatoid arthritis .

5.Organ Transplantation
The efficacy of MMF has been clearly established in renal transplantation . However, its value compared with currently used agents, for this and other conditions, is yet to be established

Future Directions
MMF has been recognized as a useful drug in the treatment of interstitial lung disease in systemic rheumatic diseases and skin fibrosis in systemic sclerosis . It is also being studied for the treatment of nephritis and other complications of autoimmune diseases . A broad array of trials with MMF are ongoing within the field of rheumatology that might provide further novel avenues for the use of this drug .

Key words: